Proposed Directors of Tirupati Graphite explain why they have requisitioned an GM. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPlexus Share News (POS)

Share Price Information for Plexus (POS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 16.50
Bid: 16.00
Ask: 17.00
Change: 0.00 (0.00%)
Spread: 1.00 (6.25%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 16.50
POS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

AIM WINNERS & LOSERS: Strip Tinning and Plexus win deals

Mon, 06th Nov 2023 10:24

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Monday.

----------

AIM - WINNERS

----------

Strip Tinning Holdings PLC, up 27% at 53.80 pence, 12-month range 35.00p-75.00p. The electrical connectors provider for the automotive sector says its Glazing arm won a "new production nomination". "The nomination is for the supply of glazing connectors to a range of leading global automotive OEMs including Mercedes, Volkswagen, Toyota and Skoda, for a number of battery and combustion engine-based vehicle programmes. Supply will commence in Q2 2024 and will continue for two to five years, depending on the end of production dates of the individual programmes," the AIM listing explains. The lifetime sales value of the pact is predicted to be EUR3 million.

----------

Plexus Holdings PLC, up 21% at 18.18 pence, 12-month range 1.60p-31.40p. The West Sussex-based engineering services provider rental contract award for its wellhead equipment offering with Neptune Energy UK. "The contract is for Adjustable Surface Wellhead equipment and Mudline Tooling to allow the permanent abandonment of a UK North Sea well, with operations planned for commencement and completion during Q2 2024," Plexus says.

----------

AIM - LOSERS

----------

Aptamer Group PLC, down 6.3% at 1.27p, 12-month range 1.02p-71.45p. Aptamer warns revenue for the half-year to December 31 is to be weaker than the GBP1.0 million achieved a year prior. The York-based biotech firm makes synthetic antibodies capable of binding to targets such as tumour cells. It has seen a "lull in customer confidence", it says.

----------

By Eric Cunha, Alliance News news editor

Comments and questions to newsroom@alliancenews.com

Copyright 2023 Alliance News Ltd. All Rights Reserved.

More News

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.